Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $23,588 | 11 | 84.7% |
| Travel and Lodging | $3,112 | 18 | 11.2% |
| Food and Beverage | $1,153 | 18 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Braeburn Inc. | $27,767 | 44 | $0 (2024) |
| USWM, LLC | $64.66 | 2 | $0 (2024) |
| ABBVIE INC. | $21.45 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,831 | 46 | Braeburn Inc. ($27,767) |
| 2023 | $21.45 | 1 | ABBVIE INC. ($21.45) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $930.00 | General |
| Category: Opioid Use Disorder | ||||||
| 11/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,860.00 | General |
| Category: Opioid Use Disorder | ||||||
| 11/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $2,790.00 | General |
| Category: Opioid Use Disorder | ||||||
| 11/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,860.00 | General |
| Category: Opioid Use Disorder | ||||||
| 11/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,860.00 | General |
| Category: Opioid Use Disorder | ||||||
| 11/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,860.00 | General |
| Category: Opioid Use Disorder | ||||||
| 11/06/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $117.76 | General |
| Category: Opioid Use Disorder | ||||||
| 11/06/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $102.92 | General |
| Category: Opioid Use Disorder | ||||||
| 11/06/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $24.12 | General |
| Category: Opioid Use Disorder | ||||||
| 11/01/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $116.28 | General |
| Category: Opioid Use Disorder | ||||||
| 11/01/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $102.93 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $693.51 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $127.87 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $96.70 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $71.65 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $71.65 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $408.59 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $295.93 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $116.28 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $71.65 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $71.63 | General |
| Category: Opioid Use Disorder | ||||||
| 10/08/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Opioid Use Disorder | ||||||
| 10/08/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: Opioid Use Disorder | ||||||
| 09/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,860.00 | General |
| Category: Opioid Use Disorder | ||||||
About Dr. Edmond Hakimi, D.O
Dr. Edmond Hakimi, D.O is a Addiction Medicine healthcare provider based in Calverton, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982919171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edmond Hakimi, D.O has received a total of $27,853 in payments from pharmaceutical and medical device companies, with $27,831 received in 2024. These payments were reported across 47 transactions from 3 companies. The most common payment nature is "Honoraria" ($23,588).
Practice Information
- Specialty Addiction Medicine
- Location Calverton, NY
- Active Since 08/11/2010
- Last Updated 07/29/2024
- Taxonomy Code 207RA0401X
- Entity Type Individual
- NPI Number 1982919171
Products in Payments
- BRIXADI (Drug) $27,767
- Lucemyra (Drug) $64.66
- VRAYLAR (Drug) $21.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.